Cargando…

Stereotactic body radiation therapy for non-small cell lung cancer: A review

Stereotactic body radiation therapy (SBRT) is the treatment of choice for medically inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search primarily based on PubMed electronic databases was completed in July 2018. Inclusion and exclusion criteria were determined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prezzano, Kavitha M, Ma, Sung Jun, Hermann, Gregory M, Rivers, Charlotte I, Gomez-Suescun, Jorge A, Singh, Anurag K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318482/ https://www.ncbi.nlm.nih.gov/pubmed/30627522 http://dx.doi.org/10.5306/wjco.v10.i1.14

Ejemplares similares

Comparison of single– and five–fraction schedules of stereotactic body radiation therapy for central lung tumours: a single institution experience
por: Ma, Sung Jun, et al.
Publicado: (2017)

Stereotactic radiotherapy for prostate cancer: A review and future directions
por: Syed, Yusef A, et al.
Publicado: (2017)

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2018)

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
por: Singh, Anurag K., et al.
Publicado: (2018)

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
por: Fernández, Castalia, et al.
Publicado: (2022)

A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
por: Farrugia, Mark K., et al.
Publicado: (2021)

Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
por: Gerum, Sabine, et al.
Publicado: (2019)

Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome
por: Farrugia, Mark, et al.
Publicado: (2021)

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
por: Ma, Sung J., et al.
Publicado: (2019)

Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2019)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
por: Bartl, Austin J., et al.
Publicado: (2022)

Dosimetric Implications of Number of Breathing Phases Used in the Definition of Internal Target Volume [ITV] in the Treatment of Non-Small Cell Lung Cancers Using Stereotactic Body Radiation Therapy (SBRT)
por: Heard, Von Darius, et al.
Publicado: (2019)

Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
por: Huang, Karen, et al.
Publicado: (2023)

Neuronal characteristics of small-cell lung cancer
por: Onganer, P U, et al.
Publicado: (2005)

Proton stereotactic body radiation therapy for non-small cell lung cancer
por: Diwanji, Tejan, et al.
Publicado: (2020)

Progress in immunotherapy for small cell lung cancer
por: Zhao, Dong, et al.
Publicado: (2020)

Concise review of stereotactic irradiation for pediatric glial neoplasms: Current concepts and future directions
por: Sager, Omer, et al.
Publicado: (2021)

Long-term outcomes of interventions for radiation-induced xerostomia: A review
por: Ma, Sung Jun, et al.
Publicado: (2019)

Treatment options for small cell lung cancer – do we have more choice?
por: Puglisi, M, et al.
Publicado: (2010)

Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors
por: Farrugia, Mark, et al.
Publicado: (2022)

Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2022)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Mechanisms of the alternative activation of macrophages and non-coding RNAs in the development of radiation-induced lung fibrosis
por: Duru, Nadire, et al.
Publicado: (2016)

Progress in treatment of small-cell lung cancer: role of CPT-11
por: Saijo, N
Publicado: (2003)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
por: Olmedo, Maria Eugenia, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Unravelling the gut-lung axis: insights into microbiome interactions and Traditional Indian Medicine's perspective on optimal health
por: Haldar, Swati, et al.
Publicado: (2023)

Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer
por: Ren, Xiao-Cang, et al.
Publicado: (2019)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
por: Aguado, Carlos, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer
por: Kim, Daniel W., et al.
Publicado: (2019)

Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
por: Iovoli, Austin J., et al.
Publicado: (2022)

Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
por: Sereno, María, et al.
Publicado: (2021)

Stereotactic body radiation therapy for centrally-located lung tumors
por: SHEN, GE, et al.
Publicado: (2014)

Frameless stereotactic body radiation therapy for multiple lung metastases
por: Li, Qilin, et al.
Publicado: (2014)

Correction to: Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Radiation exposure and reduction in the operating room: Perspectives and future directions in spine surgery
por: Narain, Ankur S, et al.
Publicado: (2017)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e34p9o0224jg03uplu6nrg2ie3